⚡️🇺🇸#TEVA #отчетность
Teva Q4 2021 Earnings
Q4 Non-GAAP EPS of $0.77 beats by $0.04.
Revenue of $4.1B (-8.9% Y/Y) misses by $180M

2022 business outlook:
Revenues are expected to be $15.6 - $16.2 billion
Non-GAAP diluted EPS is expected to be $2.40 - $2.60
Free cash flow is expected to be $1.9 - $2.2 billion